BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 13583805)

  • 1. Some biological activities of certain progestogens. I. 17 alpha-Hydroxyprogesterone 17-n-caproate.
    KESSLER WB; BORMAN A
    Ann N Y Acad Sci; 1958 Jul; 71(5):486-93. PubMed ID: 13583805
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction of marked as well as prolonged biologic activity by esterification; 17-alpha-hydroxyprogesterone caproate, a unique progestational compound.
    REIFENSTEIN EC
    Fertil Steril; 1957; 8(1):50-79. PubMed ID: 13405048
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological action of 17 alpha-hydroxyprogesterone 17-n-caproate on the reproductive processes of the rat.
    VELARDO JT
    Ann N Y Acad Sci; 1958 Jul; 71(5):542-54. PubMed ID: 13583810
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 17 alpha-hydroxyprogesterone 17-n-caproate on growth and fattening of cattle.
    GASSNER FX; REIFENSTEIN EC
    Ann N Y Acad Sci; 1958 Jul; 71(5):572-6. PubMed ID: 13583813
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 17 alpha-hydroxyprogesterone 17-n-caproate on adrenal steroid excretion.
    CLARK SL; GREENBLATT RB
    Ann N Y Acad Sci; 1958 Jul; 71(5):710-6. PubMed ID: 13583826
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of 17 alpha-hydroxyprogesterone 17-n-caproate on the reproductive performance of cattle.
    JOHNSON KR
    Ann N Y Acad Sci; 1958 Jul; 71(5):577-9. PubMed ID: 13583814
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical application of 17 alpha-hydroxyprogesterone 17-n-caproate.
    GOLD JJ; COHEN MR
    Ann N Y Acad Sci; 1958 Jul; 71(5):691-703. PubMed ID: 13583824
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in habitual abortion.
    REIFENSTEIN EC
    Ann N Y Acad Sci; 1958 Jul; 71(5):762-86. PubMed ID: 13583832
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of persistent acne in women with 17 alpha hydroxyprogesterone caproate (delalutin); a preliminary report.
    BAKER KC
    J Invest Dermatol; 1958 Nov; 31(5):247-50. PubMed ID: 13598928
    [No Abstract]   [Full Text] [Related]  

  • 10. Attempts to induce and maintain pregnancy in prepuberal mice following treatment with 17 alpha-hydroxyprogesterone 17-n-caproate.
    SMITHBERG M
    Ann N Y Acad Sci; 1958 Jul; 71(5):555-9. PubMed ID: 13583811
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-acting progestin: 17-alpha-hydroxyprogesterone-N-caproate].
    ANSELMI F; DELLA BELLA D
    Boll Soc Ital Biol Sper; 1955; 31(11-12):1639-43. PubMed ID: 13329249
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in the prevention of premature labor, and its effect upon fetal salvage.
    EICHNER E
    Ann N Y Acad Sci; 1958 Jul; 71(5):787-93. PubMed ID: 13583833
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of human diabetic pregnancies with estradiol valerate and 17 alpha-hydroxyprogesterone 17-n-caproate.
    GILLESPIE L; SEXTON LI; WHITE P
    Ann N Y Acad Sci; 1958 Jul; 71(5):794-9. PubMed ID: 13583834
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of a new long-acting progestational steroid (17-alpha-hydroxyprogesterone caproate) in the therapy of secondary amenorrhea; a preliminary report.
    COHEN MR; DRESNER MH; FRANK R; GOLD JJ
    Am J Obstet Gynecol; 1956 Nov; 72(5):1103-15. PubMed ID: 13362422
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical management of distrubances in ovarian function with long-acting steroids; estradiol valerate and 17-alpha-hydroxyprogesterone-caproate; preliminary report.
    FINKLER RS
    Fertil Steril; 1957; 8(4):323-32. PubMed ID: 13438031
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparisor of duration of action of progesterone and 17-alpha-hydroxyprogesterone-17-n-caproate.
    KESSLER WB; BORMAN A
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):820-2. PubMed ID: 13431969
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of 17-alpha-hydroxyprogesterone caproate in 100 cases of threatened abortion].
    CASTELAZO AYALA L; ESPINOSA DE LOS REYES V; GONZALEZ RAMOS M; REYES CEJA L
    Ginecol Obstet Mex; 1959; 14():249-61. PubMed ID: 13808265
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of 17 alpha-hydroxyprogesterone-4-C14-17 alpha-caproate by homogenates of rat liver and human placenta.
    WIENER M; LUPU CI; PLOTZ EJ
    Acta Endocrinol (Copenh); 1961 Apr; 36():511-9. PubMed ID: 13785108
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma.
    VARGA A; HENRIKSEN E
    Obstet Gynecol; 1961 Dec; 18():658-72. PubMed ID: 13924838
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of 17-alpha-hydroxyprogesterone caproate to maintain pregnancy.
    MEYERHOFF KH; BROWN WH; CIOFFI LA
    Curr Ther Res Clin Exp; 1962 Oct; 4():499-505. PubMed ID: 13935332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.